ArticleFrontiers in cardiovascular medicine2026
A chronological framework for atherosclerosis: from environmental pressure to clinical disease, with vascular aging as a cross-cutting dimension.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atherosclerosis is a multiphase disease, yet contemporary cardiovascular risk stratification relies predominantly on calculators that estimate event probability within a limited pathophysiological window. Framingham, SCORE2, GLOBORISK and PREVENT capture lipid burden, metabolic parameters, and renal function, but they do not organize the chronological sequence of atherogenesis, assign measurable biomarkers to each stage, or integrate vascular aging. We propose CASCADE (Chronological Atherosclerosis Staging: Connecting Aging, Disease, and Environment), a conceptual framework that applies disease staging to atherosclerosis, organizing it into seven pathophysiological phases (F1-F7) preceded by an upstream environmental and behavioral pressure layer (F0), and spanning the trajectory from adaptive metabolic response to clinical cardiovascular disease. Each phase is mapped to a proposed dominant biomarker - from insulin resistance indices through apolipoprotein B, lipoprotein(a), and coronary artery calcium - and to a reversibility zone (largely reversible, transition, or stabilization only). Vascular aging - characterized by arterial stiffness, cellular senescence, epigenetic drift, and clonal hematopoiesis - traverses all phases as a modifiable cross-cutting dimension, with specific biological clocks applicable at each stage. The framework is developed through narrative synthesis of mechanistic, epidemiological, and clinical trial evidence, integrating current international guidelines and emerging evidence on biological aging and environmental determinants of cardiovascular risk. CASCADE complements existing risk calculators by providing chronological context for the upstream phases (F0-F3), where conventional tools offer limited guidance and the potential for disease modification is greatest. It is proposed as a hypothesis-generating framework, not a validated scoring system, and invites prospective evaluation of whether individuals traverse identifiable, modifiable phases of atherosclerotic disease - and whether integrating vascular aging measurement at each stage improves risk assessment and therapeutic decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.